Dolutegravir, the Second-Generation of Integrase Strand Transfer Inhibitors (INSTIs) for the Treatment of HIV

The integrase strand transfer inhibitors (INSTIs) are the newest antiretroviral class in the HIV treatment armamentarium. Dolutegravir (DTG) is the only second-generation INSTI with FDA approval (2013). It has potential advantages in comparison to first-generation INSTI’s, including unboosted daily...

Descripción completa

Detalles Bibliográficos
Autores principales: Dow, Dorothy E., Bartlett, John A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4269626/
https://www.ncbi.nlm.nih.gov/pubmed/25134686
http://dx.doi.org/10.1007/s40121-014-0029-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4269626/
https://www.ncbi.nlm.nih.gov/pubmed/25134686
http://dx.doi.org/10.1007/s40121-014-0029-7

Ejemplares similares